Chris Wilson

Research Associate at Isomerase Therapeutics Ltd. - Cambridge, Cambridge, UK

Chris Wilson's Contact Details
HQ
Location
Company
Isomerase Therapeutics Ltd.
Chris Wilson's Company Details
Isomerase Therapeutics Ltd. logo, Isomerase Therapeutics Ltd. contact details

Isomerase Therapeutics Ltd.

Cambridge, Cambridge, UK • 50 - 99 Employees
Major Drugs

Isomerase Therapeutics is a biotechnology drug discovery and development service company exploiting the power of microbial natural products.We are uniquely placed to assist partners with their search for new highly targeted medicines, improved microbial products and the development of more cost-effective processes.We combine leading-edge synthetic biology, advanced strain bioengineering and biosynthetic medicinal chemistry approaches to discover new leads and rapidly optimise these into highly valuable drug candidates or high value products. We offer this bespoke biosynthetic engineering/semi-synthetic chemistry platform and drug discovery and development expertise on a FTE basis to partners looking for more than just a CRO. Isomerase Therapeutics can help you take your chosen natural product from an interesting hit to a high value candidate drug.

Microbial natural products Drug discovery and development Synthetic biology Biosynthetic engineering Semi-synthetic chemistry Polyketide chemistry Bioengineering Strain improvement Process improvement Genome analysis
Details about Isomerase Therapeutics Ltd.
Frequently Asked Questions about Chris Wilson
Chris Wilson currently works for Isomerase Therapeutics Ltd..
Chris Wilson's role at Isomerase Therapeutics Ltd. is Research Associate.
Chris Wilson's email address is ***@isomerase.co.uk. To view Chris Wilson's full email address, please signup to ConnectPlex.
Chris Wilson works in the Pharmaceuticals industry.
Chris Wilson's colleagues at Isomerase Therapeutics Ltd. are Lewis Tanner, Freddie Dudbridge, Marta Lalik, Sam McCormack, Freddie Dudbridge, Marta Lalik, Chris Wilson and others.
Chris Wilson's phone number is
See more information about Chris Wilson